Literature DB >> 1569206

Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene.

H C Dietz1, R E Pyeritz, E G Puffenberger, R J Kendzior, G M Corson, C L Maslen, L Y Sakai, C A Francomano, G R Cutting.   

Abstract

To examine the associations among fibrillin gene mutations, protein function, and Marfan syndrome phenotype, we screened for alterations in the fibrillin coding sequence in patients with a range of manifestations and clinical severity. A cysteine to serine substitution at codon 1409 (C1409S) was identified in an epidermal growth factor (EGF)-like motif from one fibrillin allele which segregates with the disease phenotype through three generations of a family affected with the Marfan syndrome. This alteration was not observed in 60 probands from other families or in 88 unrelated normal individuals. The altered cysteine is completely conserved in all EGF-like motifs identified in fibrillin, and in all proteins that contain this motif. These observations strongly indicate that C1409S is the disease-producing mutation in this family. The phenotype of individuals carrying C1409S varied widely with respect to onset of disease, organ-system involvement, and clinical severity; certain affected adults were unaware of their status before being diagnosed through this investigation. We conclude that fibrillin gene defects cause familial Marfan syndrome, that mutations in the EGF-like motif of the fibrillin gene are not uniformly associated with severe disease, and that fibrillin genotype is not the sole determinant of Marfan phenotype.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569206      PMCID: PMC443046          DOI: 10.1172/JCI115766

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene.

Authors:  H C Dietz; G R Cutting; R E Pyeritz; C L Maslen; L Y Sakai; G M Corson; E G Puffenberger; A Hamosh; E J Nanthakumar; S M Curristin
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

2.  Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the gene.

Authors:  K Kainulainen; B Steinmann; F Collins; H C Dietz; C A Francomano; A Child; M W Kilpatrick; D J Brock; M Keston; R E Pyeritz
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

3.  Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome.

Authors:  D W Hollister; M Godfrey; L Y Sakai; R E Pyeritz
Journal:  N Engl J Med       Date:  1990-07-19       Impact factor: 91.245

Review 4.  The Marfan syndrome: diagnosis and management.

Authors:  R E Pyeritz; V A McKusick
Journal:  N Engl J Med       Date:  1979-04-05       Impact factor: 91.245

5.  The solution structure of human epidermal growth factor.

Authors:  R M Cooke; A J Wilkinson; M Baron; A Pastore; M J Tappin; I D Campbell; H Gregory; B Sheard
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

6.  Extracellular matrix microfibrils are composed of core proteins coated with fibronectin.

Authors:  E Schwartz; S Goldfischer; B Coltoff-Schiller; O O Blumenfeld
Journal:  J Histochem Cytochem       Date:  1985-04       Impact factor: 2.479

7.  Pneumothorax in the Marfan syndrome: prevalence and therapy.

Authors:  J R Hall; R E Pyeritz; D L Dudgeon; J A Haller
Journal:  Ann Thorac Surg       Date:  1984-06       Impact factor: 4.330

8.  Microfibrils, elastic anchoring components of the extracellular matrix, are associated with fibronectin in the zonule of Zinn and aorta.

Authors:  S Goldfischer; B Coltoff-Schiller; M Goldfischer
Journal:  Tissue Cell       Date:  1985       Impact factor: 2.466

9.  Immunolocalization of type IV collagen and laminin in nonbasement membrane structures of murine corneal stroma. A light and electron microscopic study.

Authors:  B M Pratt; J A Madri
Journal:  Lab Invest       Date:  1985-06       Impact factor: 5.662

10.  Novel regulators of bone formation: molecular clones and activities.

Authors:  J M Wozney; V Rosen; A J Celeste; L M Mitsock; M J Whitters; R W Kriz; R M Hewick; E A Wang
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

View more
  40 in total

1.  Familial occurrence of typical and severe lethal congenital contractural arachnodactyly caused by missplicing of exon 34 of fibrillin-2.

Authors:  M Wang; C L Clericuzio; M Godfrey
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

Review 2.  Preventing the aortic complications of Marfan syndrome: a case-example of translational genomic medicine.

Authors:  Alain Li-Wan-Po; Bart Loeys; Peter Farndon; David Latham; Caroline Bradley
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

3.  Evolving phenotype of Marfan's syndrome.

Authors:  K J Lipscomb; J Clayton-Smith; R Harris
Journal:  Arch Dis Child       Date:  1997-01       Impact factor: 3.791

4.  Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene.

Authors:  G Collod-Béroud; C Béroud; L Adès; C Black; M Boxer; D J Brock; M Godfrey; C Hayward; L Karttunen; D Milewicz; L Peltonen; R I Richards; M Wang; C Junien; C Boileau
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

5.  Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors.

Authors:  S Hoffmeyer; P Nürnberg; H Ritter; R Fahsold; W Leistner; D Kaufmann; W Krone
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

Review 6.  Marfan syndrome in the third Millennium.

Authors:  Gwenaëlle Collod-Béroud; Catherine Boileau
Journal:  Eur J Hum Genet       Date:  2002-11       Impact factor: 4.246

7.  Parental somatic and germ-line mosaicism for a FBN2 mutation and analysis of FBN2 transcript levels in dermal fibroblasts.

Authors:  E A Putnam; E S Park; C M Aalfs; R C Hennekam; D M Milewicz
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

8.  Of mice and Marfan: genetic linkage analyses of the fibrillin genes, Fbn1 and Fbn2, in the mouse genome.

Authors:  C Goldstein; P Liaw; S A Jimenez; A M Buchberg; L D Siracusa
Journal:  Mamm Genome       Date:  1994-11       Impact factor: 2.957

Review 9.  Identification of defects in the fibrillin gene and protein in individuals with the Marfan syndrome and related disorders.

Authors:  D M Milewicz
Journal:  Tex Heart Inst J       Date:  1994

10.  Candidate gene study to investigate the genetic determinants of normal variation in central corneal thickness.

Authors:  David P Dimasi; Kathryn P Burdon; Alex W Hewitt; Ravi Savarirayan; Paul R Healey; Paul Mitchell; David A Mackey; Jamie E Craig
Journal:  Mol Vis       Date:  2010-03-31       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.